HER2-positive Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06366Pertuzumab1Completed1
DB14967MargetuximabNot AvailableTemporarily Not Available1